# Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma

> **NCT07752394** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Head & Neck Cancer

## Interventions

- **DRUG:** Finotonlimab
- **DRUG:** Nab-paclitaxel
- **DRUG:** carboplatin

## Key facts

- **NCT ID:** NCT07752394
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-23
- **Primary completion:** 2031-08-23
- **Final completion:** 2031-08-23
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07752394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07752394, "Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07752394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*